FIELD: medicine.
SUBSTANCE: lymphocyte count, relative lymphocyte count, relative CD3+lymphocyte count, absolute CD4+lymphocyte count, relative and absolute CD8+lymphocyte count, total bilirubin are evaluated. A discriminant function is described, and a graphical diagram is used for the purpose of pre-therapeutic determination of the clinical outcome of the antiviral therapy in the patients suffering chronic hepatitis B.
EFFECT: higher accuracy of prediction of the clinical courses of the conventional antivital therapy of chronic hepatitis B.
1 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF ANTIRETROVIRAL THERAPY OUTCOMES IN CHRONIC HEPATITIS B | 2014 |
|
RU2571493C2 |
| METHOD OF PREVENTION OF CHRONIC VIRAL HEPATITIS TYPE C RECURRENT AFTER VIRUS REMISSION | 2007 |
|
RU2348412C1 |
| METHOD FOR PREDICTION OF A STABLE VIROLOGIC RESPONSE TO THERAPY OF CHRONIC HEPATITIS C WITH PREPARATIONS OF DIRECT ANTIVIRAL ACTION IN THE PRESENCE OF LIPID DISTRESS SYNDROME | 2019 |
|
RU2710257C1 |
| METHOD OF PREDICTING BY BIOCHEMICAL PARAMETRES CHRONIC HEPATITIS C TREATMENT OUTCOME AFTER THREE MONTHS SINCE BEGINNING OF ANTIVIRAL THERAPY | 2009 |
|
RU2408283C1 |
| METHOD OF CHRONIC VIRUS HEPATITIS B TREATMENT | 2006 |
|
RU2365381C2 |
| METHOD OF TREATMENT OF CHRONIC VIRAL HEPATITIS TYPE C | 2006 |
|
RU2345787C2 |
| METHOD FOR PREDICTION OF DEVELOPING METABOLIC SYNDROME IN PATIENTS WITH CHRONIC VIRAL HEPATITIS C | 2018 |
|
RU2684524C1 |
| METHOD FOR PREDICTION OF LIPID DISTRESS SYNDROME DEVELOPMENT IN PATIENTS WITH STABLE VIROLOGIC RESPONSE TO ANTIVIRAL THERAPY OF CHRONIC HEPATITIS C | 2019 |
|
RU2710264C1 |
| METHOD FOR PREDICTION OF DEVELOPMENT OF LIPID DISTRESS SYNDROME IN CHRONIC VIRAL HEPATITIS C | 2019 |
|
RU2710254C1 |
| METHOD FOR REVEALING OF CHOLESTEROSIS OF GALL BLADDER AT SICK OF CHRONIC VIRUS HEPATITIS C | 2007 |
|
RU2339947C1 |
